Tag: antimicrobial resistance
Pfizer transforms Melbourne facility into cutting-edge pharmaceutical manufacturing hub
Pfizer Australia is investing AUD 150 million to upgrade its Melbourne facility into one of the country’s most advanced pharmaceutical production sites to combat antimicrobial resistance (AMR).
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
